藏药治疗结核病的研究进展  

Research Progress on Tibetan Medicine for the Treatment of Tuberculosis

作　　者：倪书奕 汪中涛[2] 何树梅[1] 

机构地区：[1]西藏民族大学医学院藏药检测技术教育部工程研究中心,陕西 咸阳 [2]西藏军区总医院感染病科,西藏 拉萨

出　　处：《临床医学进展》2024年第5期1320-1328,共9页Advances in Clinical Medicine

摘　　要：结核病是由结核分枝杆菌引起的一种慢性传染病,目前结核病患者数量以及耐药结核的发生率增加,使结核病临床治疗面临众多挑战。西藏地区结核病发病率较高,而在藏区可以因地制宜运用其特有的藏医药资源,通过就地取材的药物研发治疗结核病,以缓解因结核病带来的就业困难、农牧业劳动力不足和生活质量下降等相关问题,促进未来西藏社会经济发展。近年来有相关实验和临床研究表明,藏医药在抗结核病上有一定作用。本文对单味藏药和藏药复方抗结核病作用的研究现状进行综述,为今后藏药抗结核相关研究提供理论基础,同时为藏药的临床应用提供参考。Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis (MTB). And the current increase in the number of tuberculosis patients and the incidence of drug-resistant tuberculosis has led to numerous challenges in the clinical treatment of tuberculosis. Xizang has a high incidence of tuberculosis, and the Tibetan region can make use of its unique Tibetan medicine resources in a localized manner to treat TB, through local drug development in order to alleviate the employment difficulties, labor shortage in agriculture and animal husbandry, and decline in quality of life due to TB, and to promote the social and economic development of Xizang in the future. In recent years, there have been relevant experimental and clinical studies showing that Tibetan medicine has a certain role in anti-tuberculosis. By reviewing the research of single Tibetan medicine and complex prescription of Tibetan medicine in the treatment of tuberculosis, this article aims to provide a theoretical basis for the research related to the anti-tuberculosis of Tibetan medicines, as well as to provide a reference for the clinical application of Tibetan medicines.

关 键 词：藏药 结核病 结核分枝杆菌 抗结核 

分 类 号：R52[医药卫生—内科学]